Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Melanoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Rare Diseases 1Precancerous Conditions 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Muscle-invasive Bladder Cancer 1Multiple Myeloma 1Mesothelioma 1Lymphoma, Large B-Cell, Diffuse 1Hypertension, Portal 1Hepatitis C 1Fibrosis 1Endometrial Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 2Sunitinib 2Cisplatin 2Brentuximab Vedotin 2tremelimumab 1pralsetinib 1keyhole-limpet hemocyanin 1durvalumab 1Tetanus Toxoid 1Sirolimus 1Plicamycin 1Pemetrexed 1Paclitaxel 1Genistein 1Gemcitabine 1Gefitinib 1Erlotinib Hydrochloride 1Epirubicin 1Carboplatin 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms, Germ Cell and Embryonal × tremelimumab × Clear all
NCT03081923 2021-05-14

APACHE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Terminated
36 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡